A Phase 2/3 interventional study of Aceclofenac and Placebo in Symptomatic Irreversible Pulpitis, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-07.
Sponsored by Cairo University · Phase 2/3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 103 studies in Pain by Cairo University — 31 open to participants now, 34 under way, 2 of them phase 3. Pain · Cairo University.
Among the 103 studies in Pain by Cairo University, this one is the 39th largest by enrollment of the 100 interventional ones that give a count, is one of 11 that started in 2015, is one of 3 in phase 2/3, and was the 25th registered.
10,075 studies on the registry are indexed under Pain; 1,649 are open to participants now.
Browse Pain studies →31 of the 103 studies in Pain by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 25–45
Cairo University · Sites in Egypt
Ages 20–40 · Women only
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 20–45
Cairo University · Sites in Egypt
Ages 18–65 · Women only
By country, each count listing its studies:
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 433 (47%) stop at 75 or younger; 145 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
103 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 16 · Phase 3 9 · Phase 4 10
First in 2010; this study’s year is marked. 11 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 70 is close to the median of 66 across 8,511 interventional studies indexed under Pain.
Median enrollment 60 across the 100 interventional studies, 50 across the 3 observational. Of the 38 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,958 studies on the registry; 1,468 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
6 of the studies in Pain by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07692126Cairo UniversityCore Stability vs Scapular Stabilization on Hand Grip Strength in Chronic Myofascial Neck Pain | 2027-01-01 |
| NCT07342790Cairo UniversityArtificial Intelligence Clinical Decision | 2027-02-01 |
| NCT07664566Cairo UniversityCore Stability Exercises Versus Proprioceptive Training on Pain and Function in Patients With Patellofemoral Pain Syndrome | 2027-03-20 |
| NCT07901920Cairo UniversityPlatelets Rich Plasma Injection Versus Physiologic Saline Injection for Treatment of Myofascial Pain | 2027-05-01 |
| NCT07880821Cairo UniversityPerioperative Mirogabalin for Pain Relief After Modified Radical Mastectomy | 2027-07-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 103 studies in Pain by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this prospective, randomized, double-blind, clinical trial is to evaluate the effect of a preoperative, single, oral dose of aceclofenac (100 mg) on postendodontic pain at 6, 24 and 48 hours, postoperative pain at injection area at 6, 24 and 48 hours and analgesic intake after single-visit root canal treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Aceclofenac 100 mg tablet
Drug: Aceclofenac
Placebo
Other: Placebo
Aceclofenac 100 mg tablet given one hour before starting the root canal treatment
Also known as: Bristaflam
Placebo tablet given one hour before starting the root canal treatment
Postendodontic pain rate change
Postendodontic pain will be measured using Heft-Parker visual analogue scale. No or mild pain response will be considered success.
Time frame: At 6, 24 and 48 hours after root canal treatment.
Postoperative pain at injection area
Postoperative pain at injection area will be measured with Heft-Parker visual analogue scale. No or mild pain response will be considered success.
Time frame: At 6, 24 and 48 hours after root canal treatment.
Analgesic intake
Incidence of analgesic intake
Time frame: Within 48 hours after single root canal treatment.
Plan to share: No
Ran from May 2015 to primary completion in Jul 2017, 26 months.
Of 35 non-industry phase 2/3 interventional studies under Pain, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 26 months is above that.
Counting every sponsor, half of 41 studies reached it within 20 months; a quarter within 13 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Aceclofenac